The study covers the period of 2015-2019, before approvals for CAR T-cell therapy, pirtobrutinib, and the arrival of covalent BTK inhibitors with fewer adverse events in mantle cell lymphoma.

A comprehensive new study confirmed that GLP-1 medications such as Ozempic and Mounjaro have myriad health benefits — even more than previously thought. Analyzing the medical records of roughly 2.5 ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

Computed tomography scans have become vital, even lifesaving, medical imaging for diagnosing and monitoring health conditions. But they do expose patients to ionizing radiation at levels linked to ...

A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than ...

New multi-omic data reveal that GLP-1 signaling in the brain can drive body-wide rejuvenation, offering a potential weight-neutral path to preserving strength and organ resilience with age. Study: ...

The Keytruda-beating data from Akeso and Summit’s ivonescimab that oncology industry watchers had been awaiting are here. The China-only data are impressive, signaling the PD-1/VEGF bispecific ...

The resulting study, published in the medical journal JAMA Network Open, looked at the health data of 21,790 veterans with type 2 diabetes to compare three different GLP-1 RAs - liraglutide, ...

A new study raises critical questions about the effectiveness of the Centers for Medicare and Medicaid Services' (CMS) sepsis quality measure, known as the Severe Sepsis/Septic Shock Management Bundle ...

Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports ...